Axinn Serving as Patent Counsel for ADHD and Pain Relief Medications
May 1, 2007
Axinn represented Actavis Group in connection with its launch of multiple ADHD and pain relief medications. This representation included ongoing advice and counseling and current defense of patent litigation against generic versions of Ritalin LA®, Adderall XR® and Oxycontin.®
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
Volunteer Lawyers for the Arts – Champions of the Arts Awards and Gala 2025
Sponsorship
Antitrust
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
Cost-Effective and Efficient IP Litigation Strategies – Making Paragraph IV Litigation Work for You
Webinar
Intellectual Property
Hartford HealthCare Black and Red Gala 2025
Sponsorship
Antitrust
Informa CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
Recent Decision Shows the Heavy Burden of Actual Malice in Defamation Suits
Axinn Viewpoints
Litigation & Trials